These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31515677)

  • 21. Inhibition of morphine tolerance by MrgC receptor via modulation of interleukin-1β and matrix metalloproteinase 9 in dorsal root ganglia in rats.
    Zhang Y; Wang K; Lin M; Li Q; Hong Y
    Eur J Pharmacol; 2017 Nov; 815():10-17. PubMed ID: 28993160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and mechanism of action of etanercept in bone cancer pain.
    Liao Y; Xu M
    Pharmazie; 2017 Apr; 72(4):219-222. PubMed ID: 29441991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide alleviates bone cancer pain by down-regulating expressions of NF-κB and GFAP in spinal astrocytes in a mouse model.
    Tian J; Song T; Wang H; Wang W; Zhang Z; Yan R
    Int J Neurosci; 2019 Sep; 129(9):896-903. PubMed ID: 30806135
    [No Abstract]   [Full Text] [Related]  

  • 24. A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2.
    Lu C; Shi L; Sun B; Zhang Y; Hou B; Sun Y; Ma Z; Gu X
    Cell Mol Neurobiol; 2017 Jan; 37(1):101-109. PubMed ID: 26935064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPR30 disrupts the balance of GABAergic and glutamatergic transmission in the spinal cord driving to the development of bone cancer pain.
    Luo J; Huang X; Li Y; Li Y; Xu X; Gao Y; Shi R; Yao W; Liu J; Ke C
    Oncotarget; 2016 Nov; 7(45):73462-73472. PubMed ID: 27608844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Involvement of intrathecal activation of MrgC receptor in pathological pain and morphine tolerance].
    Li YP; Jiang JP
    Sheng Li Xue Bao; 2019 Oct; 71(5):741-748. PubMed ID: 31646328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.
    Gu X; Zhang J; Ma Z; Wang J; Zhou X; Jin Y; Xia X; Gao Q; Mei F
    Eur J Pain; 2010 May; 14(5):496-502. PubMed ID: 19815434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
    Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
    Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of cannabinoid 2 receptor in the development of bone cancer pain].
    Wang D; Ren BX; Liu CL; Zhu J; Zhang J; Zhang W; Mei FM; Gu XP; Ma ZL
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):440-3. PubMed ID: 22490961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of bone-tumor-induced spinal cord astrocyte activation and aromatase expression to mechanical hyperalgesia and cold hypersensitivity in intact female and ovariectomized mice.
    Smeester BA; O'Brien EE; Michlitsch KS; Lee JH; Beitz AJ
    Neuroscience; 2016 Jun; 324():344-54. PubMed ID: 26995084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA.
    Zhang R; Liu Y; Zhang J; Zheng Y; Gu X; Ma Z
    Pharmacol Biochem Behav; 2012 Jul; 102(1):139-45. PubMed ID: 22503970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative regulation of REST on NR2B in spinal cord contributes to the development of bone cancer pain in mice.
    Wang D; Yu J
    Oncotarget; 2016 Dec; 7(51):85564-85572. PubMed ID: 27732941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous inhibition of NMDA and mGlu1/5 receptors by levo-corydalmine in rat spinal cord attenuates bone cancer pain.
    Dai WL; Yan B; Jiang N; Wu JJ; Liu XF; Liu JH; Yu BY
    Int J Cancer; 2017 Aug; 141(4):805-815. PubMed ID: 28500623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological characterization of rat Mas-related G-protein-coupled receptor C and functional analysis of agonists.
    Hager UA; Hein A; Lennerz JK; Zimmermann K; Neuhuber WL; Reeh PW
    Neuroscience; 2008 Jan; 151(1):242-54. PubMed ID: 18065157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory Effects of Mas-Related Gene C Receptor on Chronic Morphine-Induced Spinal Glial Activation in Rats.
    Zhang Y; Wang M; Lu Q; Li Q; Lin M; Huang J; Hong Y
    J Pharmacol Exp Ther; 2019 Feb; 368(2):237-245. PubMed ID: 30487293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin-mediated receptor degradation contributes to development of tolerance to MrgC agonist-induced pain inhibition in neuropathic rats.
    Huang Q; Ford NC; Gao X; Chen Z; Guo R; Raja SN; Guan Y; He S
    Pain; 2021 Apr; 162(4):1082-1094. PubMed ID: 33110031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice.
    Liu Y; Liang Y; Hou B; Liu M; Yang X; Liu C; Zhang J; Zhang W; Ma Z; Gu X
    Pharmacol Biochem Behav; 2014 Sep; 124():19-26. PubMed ID: 24836181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockage of spinal endothelin A receptors attenuates bone cancer pain via regulation of the Akt/ERK signaling pathway in mice.
    Han MM; Yang CW; Cheung CW; Li J
    Neuropeptides; 2018 Apr; 68():36-42. PubMed ID: 29395120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the mas-related gene (Mrg) C receptor agonist BAM6-22 on nociceptive reflex activity in naive, monoarthritic and mononeuropathic rats after intraplantar and intrathecal administration.
    Schröder W; Alique M; Herrero JF
    Eur J Pharmacol; 2016 Jan; 770():147-53. PubMed ID: 26617367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
    Forte BL; Slosky LM; Zhang H; Arnold MR; Staatz WD; Hay M; Largent-Milnes TM; Vanderah TW
    Pain; 2016 Dec; 157(12):2709-2721. PubMed ID: 27541850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.